News – Page 37 – Alligator Bioscience

2020-04-20

Alligator Bioscience’s Board of Directors reduces its fees and offers possibility for postal voting in front of the Annual General Meeting

Lund, Sweden, April 20, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company's Nomination Committee, ...

2020-04-07

Regulatory

Lund, Sweden, 7 April 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), announced today that the company has decided to increase its fo ...

2020-04-01

Regulatory

Lund, Sweden, 1 April 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), announced today a temporary halt in the recruitment of new pati ...

2020-03-31

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis ...

2020-03-05

Lund, Sweden, 5 March 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that Andreas Johannesson has been appointed inte ...

2020-03-022023-02-01

Regulatory

Lund, Sweden, 2 March 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceutica ...

2020-02-12

Regulatory